Key result
Chemotherapy and radiotherapy for primary cardiac lymphoma resulted in complete remission and the disappearance of ventricular tachycardia and complete atrioventricular block for 8 years.
Case Report (n=1)
Chemotherapy and radiotherapy can lead to long-term survival and the reversal of ventricular tachycardia and complete atrioventricular block in patients with primary cardiac lymphoma.
Answers are grounded in this paper and cite their sources.
Supports arrhythmia resolution with oncologic therapy in primary cardiac lymphoma; leaves open generalizability beyond this single case.
We report a long-term survival case of primary cardiac lymphoma with reversible ventricular tachycardia (VT) and complete atrioventricular block (C-AVB). A 65-year-old man with VT was treated by oral amiodarone administration. Later, a dual-chamber pacemaker was implanted because of C-AVB. Then, he was readmitted, as he complained of fever and chest pain. Echocardiography showed an enlarged cardiac mass and thus an open-chest biopsy was performed. He was then diagnosed with primary cardiac lymphoma. The chemotherapy and radiotherapy resulted in the disappearance of the mass. Complete remission has been maintained for 8 years after the therapy, and no VT or C-AVB has been detected.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2009) conducted a case report in Primary cardiac lymphoma (n=1). Chemotherapy and radiotherapy was evaluated on Tumor response and arrhythmia resolution. Chemotherapy and radiotherapy for primary cardiac lymphoma resulted in complete remission and the disappearance of ventricular tachycardia and complete atrioventricular block for 8 years.
Synapse has enriched 10 related papers. Consider them for comparative context: